Navigation Links
Two screen test and treat screening for cervical cancer

Researchers from University of Cape Town, South Africa have found effective results using Two screen and treat cervical cancer prevention programs in women with high-risk for // cervical cancer using low resource settings exclusively for developing and under developed countries. The study results showed that the test and treat program was very much effective in considerably reducing the prevalence of cervical cancer and precancerous cervical lesions.

Cervical Cancer:
Cervical cancer in women causes more than 233,000 deaths worldwide and more than 471,000 cases are diagnosed positive for cervical cancer each year, of which 80 percent occur in less-developed countries. The lifetime risk of a woman developing cervical cancer in a low-resource setting is approximately 2 percent to 4 percent.

Screen and Treat Program:
Cytological testing for cervical cancer is useful tool in diagnosing cervical cancer in women but due to the high cost of the test it has become less affordable by the economically weaker section. To overcome this and give a better identification and treatment process, Professor Lynette Denny, M.D., Ph.D., of the University of Cape Town, South Africa, and colleagues conducted a study to determine the safety and efficacy of two screen-and-treat approaches for cervical cancer prevention.

This Two screen and treat procedure does not require complex health infrastructure required by traditional approaches. The testing process uses Non-cytological techniques such as testing for Human Papilloma Virus (HPV) DNA testing and/or Visual Inspection with Acetic acid (VIA). The testing procedure is followed by treatment of lesions using Cryotherapy using nitrous oxide on lesions to freeze the lesion at low therapy. The study was conducted in 6,555 non-pregnant women, aged 35 to 65 years, and was conducted between June 2000 and December 2002 at ambulatory women’s health clinics in Khayelitsha, South Africa. All patients were scree ned using human Papilloma virus (HPV) DNA testing and visual inspection with VIA.

The researchers found that using Two screen and treat procedures the incidence of cervical cancers and cervical lesions was diagnosed early and it offers a great option of treating the cancer lesions by using Cryotherapy effectively even in economically weaker section using reduced hospital equipments.

Experts View:
Professor Lynette Denny and his team said, This trial has shown that screening and treating women based on the results of two alternative screening tests to cytology, HPV DNA testing and VIA, is safe and has a significant impact on the prevalence of CIN 2+ among women participating in such a program. In low-resource settings, screen-and-treat approaches may be able to reduce the risk of a common and easily preventable cancer in women.

Paul D. Blumenthal, M.D., M.P.H., of Johns Hopkins University, Baltimore said, When faced with a challenge, identifying and seizing an opportunity can be the first step toward triumph. That is what public health approaches are often about. An important lesson from the work of Brewster et al and Denny et al is that whether in southern California or southern Africa, safe, acceptable, effective, and pragmatic public health approaches to cervical cancer prevention can be designed

Related medicine news :

1. A sunscreen from the sea
2. Need for Colon cancer screening
3. DNA biochip for genetic screening
4. Breast screening among diabetic women
5. Fast screening for macular degeneration
6. Inadequate proof to justify routine prostate screen
7. New virtual colonoscopy procedure for easier colon screening
8. Hearing loss can be detected by simple screening
9. MRI screenings may be better to identify breast cancer
10. Oral cancer screenings to reduce the mortality rates
11. Appendectomy need reduced with CT screening
Post Your Comments:

(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... PurhealthRX ... CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will ... and providing a CBD form that can be easily incorporated into liquid products, while ...
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills ... specialty vendors and unique items from across the nation, this holiday-themed event will raise ... offered by the VNA. The boutique will be open Saturday, November 4 (10:00 ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Planet Fitness, one ... U.S., announced today its plans to open a flagship location in Covington, LA at ... former Rooms To Go store next to Office Depot in the Holiday Square shopping ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans Bioscience ... the use of wearable and home sensors for real-time ... Early Signal Foundation, a nonprofit organization focused on disruptive ... provide an affordable analytical system to record and integrate ... ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
(Date:9/19/2017)... Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company ... destruction of targeted tissues, announced three leadership team developments today:   ... PhD ... ... Veteran medical device executive Josh ...
Breaking Medicine Technology: